This website is not for investment purposes. Contact the company for investing documents.

Copyright © 2019 SageMedic Corporation. All rights reserved.

January 11, 2019

SageMedic Present at DeepTech Summit Conference

SageMedic will present at the DeepTech Summit. Qualified investors may review our technology and meet with our top management. Contact Suzie Thigpen to arrange a meeting at sthigpen@sagemedic.com 

January 7-10, 2019

JP Morgan Healthcare Conference Week

SageMedic will present at the Biotech Showcase associated with the JP Morgan Healthcare Conference week. The presentation is scheduled for January 8, 2019 at 10:15 am. Qualified investors may review our technology and meet with our top management. Contact Suzie Thigpen to arrange a meeting at sthigpen@sagemedic.com 

October 30, 2018

SageMedic Presents at NYC Oncology Conference

SageMedic presented to the NYC Oncology Conference where the latest developments in oncology and a select group of exceptional investment opportunities in precision medicine, diagnostics, etc. present. Key opinion leaders in the field of oncology, as well as life science investors led discussions on challenges and opportunities in oncology. 

August 3, 2018

Dr. Apfel, CEO of SageMedic, Interviews at Nasdaq Market Site

August 22-24, 2018

SageMedic Presents at Keiretsu Northern California Chapter

Keiretsu Forum is a global investment community of accredited private equity angel investors, venture capitalists and corporate/institutional investors. Because Keiretsu Forum was SageMedic's Seed round audience, where SageMedic received so much attention and was oversubscribed. It only made sense to bring the Keiretsu members the Bridge round opportunity before SageMedic moved on to the Series A round.

August 23, 2018

SageMedic Awarded "Most Valuable Company" Award at Keiretsu Pacific Northwest Capital Expo

SageMedic was well received and really got the audience interested in functional precision medicine. With an excellent presentation and interaction throughout the night, SageMedic was able to keep the topic hot and was voted the Most Valuable Company by the audience.

August 23, 2018

SageMedic Presents at Keiretsu Pacific NorthWest Capital Expo, Washington 

Keiretsu forum was SageMedic's Seed round audience, where SageMedic received so much attention and was oversubscribed. It only made sense to bring the Keiretsu members the Bridge round opportunity before SageMedic moved on to the Series A round.

May 6, 2018

SageMedic Presents at NYC Oncology Conference

NYC Oncology is a conference where the latest developments in oncology and a select group of exceptional investment opportunities in precision medicine, diagnostics, etc. present. Key opinion leaders in the field of oncology, as well as life science investors will lead discussions on challenges and opportunities in oncology. SageMedic presented the end of the Seed round at this conference.

March 26, 2018

SageMedic is a Finalist at LyfeBulb-Helsinn Innovation Summit

SageMedic was selected as one of the finalists of the Lyfebulb/Helsinn Innovation Summit in Monte-Carlo, Monaco, March 26, 2018, with all travel expenses paid.

May 2018

SageMedic Selected to Present at Swedish American Life Science Summit

May 79, 2017

SageMedic Selected to Present at Cavendish Global Health Impact Forum

The Forum provides an environment for family offices, foundations and impact investors to develop and implement their individual pro-social impact investing, grant-giving, and philanthropy programs within health and the life sciences. Michael Moffat, Cavendish co-founder and Chairman explains, “The quality and originality of SageMedic’s research and scientific insights in 3D micro-tumor assays positions them to make a major contribution to  improving patient outcomes by giving physicians the data they need to make better informed cancer treatment decisions.”